Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 June 2008, Vol. 111, No. 12, pp. 5592-5600.
Prepublished online as a Blood First Edition Paper on April 7, 2008; DOI 10.1182/blood-2007-10-113951.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2007-10-113951v1
111/12/5592    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, B.
Right arrow Articles by Ginsburg, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, B.
Right arrow Articles by Ginsburg, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 11, 2007
Accepted March 31, 2008

Genotype-phenotype correlation in combined deficiency of factor V and factor VIII

Bin Zhang*, Marta Spreafico, Chunlei Zheng, Angela Yang, Petra Platzer, Michael U Callaghan, Zekai Avci, Namik Ozbek, Johnny Mahlangu, Tabitha Haw, Randal J Kaufman, Kandice Marchant, EGD Tuddenham, Uri Seligsohn, Flora Peyvandi, and David Ginsburg

Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States
A. Bianchi Bonomi Hemophilia & Thrombosis Centre, Univ of Milan, and Dept of Medicine & Medical Spec, Luigi Villa Foundation, IRCCS Maggiore Hospital, Mangiagalli & Regina Elena Foundation, Milan, Italy
Life Sciences Institute, Depts of Internal Medicine and Human Genetics, University of Michigan, Ann Arbor, MI, United States
Children's Hospital of Michigan, Wayne State University, Detroit, MI, United States
Department of Pediatric Hematology, Baskent University Faculty of Medicine, Ankara, Turkey
National Health Laboratory Service, and University of the Witwatersrand, Johannesburg, South Africa
Departments of Biological Chemistry and Internal Medicine, University of Michigan, Ann Arbor, MI, United States
Pathology and Lab Medicine Division, Cleveland Clinic Foundation, Cleveland, OH, United States
Hemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, United Kingdom
Institute of Thrombosis & Hemostasis, Sheba Medical Center, Tel-Hashomer, Israel
Life Sciences Institute, Dept of Internal Medicine and Human Genetics, University of Michigan, Ann Arbor, MI, United States

* Corresponding author; email: zhangb{at}ccf.org.

Combined deficiency of factor V and factor VIII (F5F8D) is caused by mutations in one of two genes, either LMAN1 or MCFD2. Here we report the identification of mutations for 11 additional F5F8D families, including 4 novel mutations, 2 in MCFD2 and 2 in LMAN1. We show that a novel MCFD2 missense mutation identified here (D81Y) and 2 previously reported mutations (D89A and D122V) abolish MCFD2 binding to LMAN1. Measurement of platelet factor V (FV) levels in 7 F5F8D patients (4 with LMAN1 and 3 with MCFD2 mutations), demonstrated similar reductions to those observed for plasma FV. Combining the current data together with all previous published reports, we performed a genotype-phenotype analysis comparing patients with MCFD2 mutations to those with LMAN1 mutations. A previously unappreciated difference is observed between these two classes of patients in the distribution of plasma levels for FV and factor VIII (FVIII). Although there is considerable overlap, the mean levels of plasma FV and FVIII in patients with MCFD2 mutations are significantly lower than the corresponding levels in patients with LMAN1 mutations. No differences in distribution of factor levels are observed by gender. These data suggest that MCFD2 may play a primary role in the export of FV and FVIII from the ER, with the impact of LMAN1 mediated indirectly through its interaction with MCFD2.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020